Filing Flows

Filing Flows › Thermo Fisher Scientific (TMO) › How it makes money

How Thermo Fisher Scientific (TMO) makes money

Thermo Fisher Scientific (TMO) made $12.1B of revenue in the third quarter 2026 (Q3 2026), +9% from a year earlier. Laboratory Products and Biopharma Services brought in $6.8B (56%); Life Sciences Solutions brought in $2.3B (19%); Analytical Instruments brought in $1.9B (16%). Of every dollar of revenue, 19¢ was left as operating profit, 14¢ was left as net earnings.

Drawing the Sankey…

Thermo Fisher Scientific revenue by segment, Q3 2026Thermo Fisher Scientific revenue by segment, Q3 2026Laboratory Products and Biopharma…$6.8BLife Sciences Solutions$2.3BAnalytical Instruments$1.9BSpecialty Diagnostics$1.1B
Thermo Fisher Scientific: revenue by line, Q1 2025 to Q3 2026Thermo Fisher Scientific: revenue by line, Q1 2025 to Q3 2026Laboratory Products a…Life Sciences Solutio…Analytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma Services: $6.8B latest$6.8BLife Sciences Solutions: $2.3B latest$2.3BAnalytical Instruments: $1.9B latest$1.9BSpecialty Diagnostics: $1.1B latest$1.1BQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Laboratory Products and Biopharma Services went from 54% of revenue in Q1 2025 to 56% in Q3 2026, the largest shift in the mix.
Thermo Fisher Scientific revenue by quarterThermo Fisher Scientific revenue by quarter$10.4BQ1 2025$10.9BQ2 2025$11.1BQ3 2025$12.2BQ4 2025$11.0BQ1 2026$12.0BQ2 2026$12.1BQ3 2026
Thermo Fisher Scientific: where each dollar of revenue goesThermo Fisher Scientific: where each dollar of revenue goesOperating profit19¢Income tax3¢Net earnings14¢Operating cash flow21¢Free cash flow17¢

Revenue by segment, Q3 2026

SegmentRevenueShareQ/QY/Y
Laboratory Products and Biopharma Services$6.8B56.2%+3%+15%
Life Sciences Solutions$2.3B18.8%-3%+4%
Analytical Instruments$1.9B16.1%+8%+5%
Specialty Diagnostics$1.1B9.0%-8%-6%

Where each dollar of revenue goes

LineQ3 2026% of revenue
Revenue$12.1B100.0%
Operating profit$2.3B18.6%
Income tax$352M2.9%
Net earnings$1.7B14.2%
Operating cash flow$2.5B21.0%
Free cash flow$2.1B17.4%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q3 2026$12.1B+9%
Q2 2026$12.0B+10%
Q1 2026$11.0B+6%
Q4 2025$12.2B+7%
Q3 2025$11.1B+5%
Q2 2025$10.9B+3%
Q1 2025$10.4B+0.2%

From Thermo Fisher Scientific's 10-Q filed Oct 30, 2026 (on EDGAR).

Questions

How does Thermo Fisher Scientific make money?

Thermo Fisher Scientific (TMO) made $12.1B of revenue in the third quarter 2026 (Q3 2026), +9% from a year earlier. Laboratory Products and Biopharma Services brought in $6.8B (56%); Life Sciences Solutions brought in $2.3B (19%); Analytical Instruments brought in $1.9B (16%). Of every dollar of revenue, 19¢ was left as operating profit, 14¢ was left as net earnings.

What is Thermo Fisher Scientific's biggest business?

Laboratory Products and Biopharma Services: $6.8B in the third quarter 2026, 56% of revenue, +15% from a year earlier.

What is Thermo Fisher Scientific's profit margin?

Net earnings were $1.7B, 14.2% of revenue, in the third quarter 2026; the operating margin was 18.6%.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.